Atlas Trials

Non-squamous NSCLC

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-squamous NSCLC

RecordFirmDate
A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer (NCT04466917)Amgen2021-05-15
Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy (NCT04447118)Jiangsu HengRui Medicine Co., Ltd.2020-09-11
AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC (NCT04413201)Michael Hopp2020-09-11
Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC (NCT05261438)Hunan Province Tumor Hospital2019-09-01
Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020） (NCT03755869)First Affiliated Hospital Xi'an Jiaotong University2018-11-29
Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients (NCT02454842)Rain Oncology Inc2015-06-01

Track Non-squamous NSCLC automatically

Every clearance here is in the API, with alerts when new ones post.